Children's Health Ireland
- Address
- lock Available on a paid plan
Immune System Diseases
The Paediatric Allergy unit at Children's Health Ireland is advancing research in peanut allergy by evaluating novel immunotherapy approaches designed to safely desensitize young children and reduce severe reactions.
- Desensitization strategies for food allergies
- Safety and tolerability assessments in early childhood
- Long‑term effectiveness of allergen‑specific therapy
These studies aim to improve everyday management of food‑triggered anaphylaxis and provide families with reliable treatment options.
Musculoskeletal Diseases
Research in the department focuses on Achondroplasia, a genetic growth disorder, by testing long‑term subcutaneous dosing of TransCon CNP to support normal bone growth and stature in children and adolescents.
- Growth modulation and height outcomes
- Bone development and skeletal health monitoring
- Patient‑reported quality of life measures
The goal is to establish a safe, effective therapy that can change the natural course of this condition and enhance daily functioning.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 45 other sites in Ireland
Therapeutic Area Benchmark — Ireland
Select a therapeutic area to compare against other sites in Ireland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Ireland
Market Share
Country: Ireland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Children's Health Ireland
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of Epicutaneous Immunotherapy with DBV712 250 μg in 4-7-year-old Children with Peanut Allergy (VITESSE) | Dbv Technologies | Phase III | Not Recruiting | Jan 2024 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Arachis Hypogaea (762) | 1 | Unknown | 2024-01-18 | 2024-01-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.